- Home
- ODV vs XOMA Comparison
ODV vs XOMA Comparison
Compare ODV & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ODV
- XOMA
- Stock Information
- Founded
- ODV 2005
- XOMA 1981
- Country
- ODV Canada
- XOMA United States
- Employees
- ODV N/A
- XOMA N/A
- Industry
- ODV Precious Metals
- XOMA Biotechnology: Pharmaceutical Preparations
- Sector
- ODV Basic Materials
- XOMA Health Care
- Exchange
- ODV Nasdaq
- XOMA Nasdaq
- Market Cap
- ODV 338.9M
- XOMA 330.2M
- IPO Year
- ODV N/A
- XOMA N/A
- Fundamental
- Price
- ODV $2.72
- XOMA $32.47
- Analyst Decision
- ODV
- XOMA Strong Buy
- Analyst Count
- ODV 0
- XOMA 2
- Target Price
- ODV N/A
- XOMA $69.50
- AVG Volume (30 Days)
- ODV 1.1M
- XOMA 57.0K
- Earning Date
- ODV 08-12-2025
- XOMA 08-13-2025
- Dividend Yield
- ODV N/A
- XOMA N/A
- EPS Growth
- ODV N/A
- XOMA N/A
- EPS
- ODV N/A
- XOMA N/A
- Revenue
- ODV $5,147,156.00
- XOMA $44,952,000.00
- Revenue This Year
- ODV $381.12
- XOMA $82.30
- Revenue Next Year
- ODV $256.81
- XOMA $12.59
- P/E Ratio
- ODV N/A
- XOMA N/A
- Revenue Growth
- ODV N/A
- XOMA 194.98
- 52 Week Low
- ODV $1.16
- XOMA $18.35
- 52 Week High
- ODV $2.91
- XOMA $35.23
- Technical
- Relative Strength Index (RSI)
- ODV 60.30
- XOMA 61.79
- Support Level
- ODV $2.43
- XOMA $32.60
- Resistance Level
- ODV $2.91
- XOMA $34.60
- Average True Range (ATR)
- ODV 0.14
- XOMA 1.82
- MACD
- ODV 0.02
- XOMA 0.09
- Stochastic Oscillator
- ODV 64.08
- XOMA 66.75
About ODV Osisko Development Corp.
Osisko Development Corp is a mineral exploration and development company engaged in the acquisition, exploration, and development of precious metals resource properties in North America. The company is focused on exploring and developing its mining assets, including the Cariboo Gold Project in British Columbia, the San Antonio gold project in Mexico, and the Trixie test mine in the USA. The Company manages its business through the exploration, evaluation, and development activities of its projects.
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.